Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
The Vanguard Group reported a 7.50% stake in Iovance Biotherapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 7.50% stake in Iovance Biotherapeutics, Inc., 25,076,472 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 25,076,472
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.50% | 25,076,472 |
Source
Related
- Iovance Biotherapeutics, Inc.
- The Vanguard Group
- Iovance Biotherapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026